An Open-Label, Multicenter Phase IB Study of the Safety and Efficacy of Atezolizu-L1 Antibody) Administered in Combination with Bevacizumab and/or Other Treatments in Patients with Solid Tumors (G030140) – Arm F Only

Project: Research

Project Details

StatusActive
Effective start/end date16/11/1815/11/22